Published online Jun 21, 2013. doi: 10.3748/wjg.v19.i23.3531
Revised: April 11, 2013
Accepted: April 28, 2013
Published online: June 21, 2013
Core tip: The efficacy of short-term treatment of microscopic colitis with budesonide is confirmed. Long-term therapy is not advisable because of possible side effects, but the efficacy of alternative drugs such as immunosuppressants or anti-tumor necrosis factor agents remains to be established. For the time being prolonged budesonide treatment in minimal doses, tailored on the single patient, appears to be the most sensible option.